Julià, Antonio
Bonafonte-Pardàs, Irene
Gómez, Antonio
López-Lasanta, María
López-Corbeto, Mireia
Martínez-Mateu, Sergio H.
Lladós, Jordi
Rodríguez-Nunez, Iván
Myers, Richard M.
Marsal, Sara
Article History
Received: 28 June 2020
Accepted: 12 May 2021
First Online: 1 June 2021
Competing interests
: SM and RMM are co-founders of IMIDomics, a biotech company in precision medicine for immune-mediated inflammatory diseases. AJ is also affiliated with IMIDomics. The other authors declare no competing interests.